findmyKOL

Ali Dabestani, MD

Basic profile

University of California, Irvine Medical Center

ORCIDNone on fileNPI
RegionLaguna Hills, CA · WestSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2017Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ali Dabestani is a Cardiology physician affiliated with University of California, Irvine Medical Center. OpenAlex indexes 25 publications with 1,801 citations (h-index 17).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
25publications

Distinct works indexed by OpenAlex.

1,801citations

Total citations across indexed works.

17h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

25401 Cabot Rd
107
Laguna Hills, CA 926535524

Telephone

949-770-4858

Registry record last updated 20 Feb 2012.

View the NPPES registry record

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    79.1%
    Beta blocker23.6%
    Carvedilol59%Metoprolol Succinate32%Metoprolol Tartrate10%
    Part D<11 patients
    Statin18%
    Rosuvastatin Calcium58%Atorvastatin Calcium42%
    Part D26 patients

    + 7 more classes in this area

  • Blood & clotting

    12.1%
    P2Y12 inhibitor8%
    Clopidogrel100%
    Part D17 patients
    Factor Xa inhibitor4.1%
    Xarelto52%Eliquis48%
    Part D<11 patients
  • Metabolism & gastrointestinal

    4.5%
    Potassium supplement2.5%
    Potassium Chloride100%
    Part D<11 patients
    Proton pump inhibitor2%
    Omeprazole100%
    Part D<11 patients
Where care is delivered (Part B)42.6% facility · 57.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”